Biomarkers for severe COVID-19

被引：10
|
作者：
Li, Xin [1 ,2 ]
To, Kelvin K. W. [1 ,2 ]
机构：
[1] Univ Hong Kong, Queen Mary Hosp, Dept Microbiol,Li Ka Shing Fac Med, State Key Lab Emerging Infect Dis,Carol Yu Ctr In, Hong Kong, Peoples R China
[2] Queen Mary Hosp, Dept Microbiol, Hong Kong, Peoples R China
来源：
EBIOMEDICINE | 2021年 / 68卷
关键词：
D O I：
10.1016/j.ebiom.2021.103405
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach
    Yayoi Kimura
    Yusuke Nakai
    Jihye Shin
    Miyui Hara
    Yuriko Takeda
    Sousuke Kubo
    Sundararaj Stanleyraj Jeremiah
    Yoko Ino
    Tomoko Akiyama
    Kayano Moriyama
    Kazuya Sakai
    Ryo Saji
    Mototsugu Nishii
    Hideya Kitamura
    Kota Murohashi
    Kouji Yamamoto
    Takeshi Kaneko
    Ichiro Takeuchi
    Eri Hagiwara
    Takashi Ogura
    Hideki Hasegawa
    Tomohiko Tamura
    Takeharu Yamanaka
    Akihide Ryo
    Scientific Reports, 11
  • [42] Pharmacodynamic, prognostic, and predictive biomarkers in severe and critical COVID-19 patients treated with sirukumab
    Thys, Kim
    Loza, Matthew J.
    Lynn, Linghua
    Callewaert, Katleen
    Varma, Lisa
    Crabbe, Marjolein
    Van Wesenbeeck, Liesbeth
    Van Landuyt, Erika
    De Meyer, Sandra
    Aerssens, Jeroen
    Verbrugge, Inge
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [43] Diagnostic Values of Laboratory Biomarkers in Predicting a Severe Course of COVID-19 on Hospital Admission
    Tummala, Anusha
    Ramesh, Venkat
    Balakrishna, Nagalla
    Koyyada, Rajeswari
    Singh, Anula Divyash
    Patnam, Sreekanth
    Satish Kumar, M.
    Varahala, Sneha
    Manda, Sasidhar V.
    Narreddy, Suneetha
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [44] Predictive biomarkers of mortality in patients with severe COVID-19 hospitalized in intensive care unit
    Medeiros, Sandrelli Meridiana de Fatima Ramos dos Santos
    Lino, Bruna Maria Nepomuceno Sousa
    Perez, Vinicius Pietta
    Sousa, Eduardo Sergio Soares
    Campana, Eloiza Helena
    Miyajima, Fabio
    Carvalho-Silva, Wlisses Henrique Veloso
    Dejani, Naiara Naiana
    Fernandes, Matheus Santos de Sousa
    Yagin, Fatma Hilal
    Al-Hashem, Fahaid
    Elkholi, Safaa M.
    Alyami, Hanan
    Souto, Fabricio Oliveira
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [45] Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID-19
    Lee, Anna
    Nahm, Chung Hyun
    Lee, Jin-Soo
    Lee, Mi-Kyeong
    Lee, Kyoung-Ryul
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (11)
  • [46] Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach
    Kimura, Yayoi
    Nakai, Yusuke
    Shin, Jihye
    Hara, Miyui
    Takeda, Yuriko
    Kubo, Sousuke
    Jeremiah, Sundararaj Stanleyraj
    Ino, Yoko
    Akiyama, Tomoko
    Moriyama, Kayano
    Sakai, Kazuya
    Saji, Ryo
    Nishii, Mototsugu
    Kitamura, Hideya
    Murohashi, Kota
    Yamamoto, Kouji
    Kaneko, Takeshi
    Takeuchi, Ichiro
    Hagiwara, Eri
    Ogura, Takashi
    Hasegawa, Hideki
    Tamura, Tomohiko
    Yamanaka, Takeharu
    Ryo, Akihide
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [47] Prognostic role of simple inflammatory biomarkers in patients with severe COVID-19: an observational study
    Ntalouka, M. P.
    Pantazopoulos, I
    Brotis, A. G.
    Pagonis, A.
    Vatsiou, I
    Chatzis, A.
    Rarras, C. N.
    Kotsi, P.
    Gourgoulianis, K., I
    Arnaoutoglou, E. M.
    HIPPOKRATIA, 2022, 26 (02) : 70 - 77
  • [48] Parallels in Sepsis and COVID-19 Conditions: Implications for Managing Severe COVID-19
    Olwal, Charles Ochieng'
    Nganyewo, Nora Nghuchuzie
    Tapela, Kesego
    Djomkam Zune, Alexandra Lindsey
    Owoicho, Oloche
    Bediako, Yaw
    Duodu, Samuel
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [49] Metformin use and risk for COVID-19 infection and severe COVID-19 outcomes
    Dublin, Sascha
    Kuntz, Jennifer
    Floyd, James
    Walker, Rod
    Fortmann, Stephen
    Bayliss, Elizabeth
    Shortreed, Susan
    Harrington, Laura
    Lee, Mi
    Albertson-Junkans, Ladia
    Powers, John
    Fuller, Sharon
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 506 - 506
  • [50] Diabetes severity and the risks of COVID-19 infection and severe COVID-19 outcomes
    Dublin, Sascha
    Floyd, James
    Walker, Rod
    Kuntz, Jennifer
    Shortreed, Susan
    Fortmann, Stephen
    Bayliss, Elizabeth
    Harrington, Laura
    Fuller, Sharon
    Albertson-Junkans, Ladia
    Powers, John
    Lee, Mi
    Temposky, Lisa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 40 - 40
12345